Literature DB >> 10488885

B notifications and the detection of tuberculosis among foreign-born recent arrivals in California.

S Sciortino1, J Mohle-Boetani, S E Royce, D Will, D P Chin.   

Abstract

OBJECTIVE: To evaluate the effectiveness and limitations of the B notification program for detecting tuberculosis among recent foreign-born arrivals in California.
DESIGN: Retrospective cohort study. All foreign-born visa holders with a B notification who arrived in California from January 1992 through September 1995 (n = 27 412) were matched with a listing of foreign-born persons who arrived in the US during the same time period and who were reported to have active tuberculosis in California within one year of their arrival from January 1992 through September 1996 (n = 2547).
RESULTS: Overall, 3.5% (95% confidence interval 3.3%, 3.8%) of all persons with a B notification were reported to have active tuberculosis within a year of arrival. Recent arrivals with a B notification and tuberculosis accounted for 38% of all foreign-born cases of tuberculosis reported within one year of arrival. Compared to recent arrivals without a B notification, those with a B notification were more likely to have pulmonary tuberculosis, less likely to have smear-positive pulmonary disease and reported with tuberculosis sooner after their arrival in the US. The B notification program was not able to identify 87% of the smear-positive pulmonary tuberculosis cases in adults, and did not identify 99% of these highly infectious cases among Latin Americans.
CONCLUSIONS: Although the evaluation of persons who enter the US with B notifications has a high yield for identifying active tuberculosis cases, it was not able to identify the majority of recent arrivals with the most infectious form of tuberculosis.

Entities:  

Mesh:

Year:  1999        PMID: 10488885

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  7 in total

1.  Impact of port of entry referrals on initiation of follow-up evaluations for immigrants with suspected tuberculosis: Illinois.

Authors:  Teal R Bell; NoelleAngelique M Molinari; Sena Blumensaadt; Monica U Selent; Michael Arbisi; Neha Shah; Demian Christiansen; Rossanne Philen; Benjamin Puesta; Joshua Jones; Deborah Lee; Arnold Vang; Nicole J Cohen
Journal:  J Immigr Minor Health       Date:  2013-08

2.  Effect of a culture-based screening algorithm on tuberculosis incidence in immigrants and refugees bound for the United States: a population-based cross-sectional study.

Authors:  Yecai Liu; Drew L Posey; Martin S Cetron; John A Painter
Journal:  Ann Intern Med       Date:  2015-03-17       Impact factor: 25.391

3.  Postarrival Tuberculosis Screening of High-Risk Immigrants at a Local Health Department.

Authors:  Jennifer B Nuzzo; Jonathan E Golub; Patrick Chaulk; Maunank Shah
Journal:  Am J Public Health       Date:  2015-01-20       Impact factor: 9.308

4.  Tuberculosis among foreign-born children in the state of Florida, 1993-1999: a re-emergence phase after a sustained decline?

Authors:  Hamisu M Salihu; Robyn Spittle
Journal:  Wien Klin Wochenschr       Date:  2003-09-30       Impact factor: 1.704

5.  Estimating the impact of newly arrived foreign-born persons on tuberculosis in the United States.

Authors:  Yecai Liu; John A Painter; Drew L Posey; Kevin P Cain; Michelle S Weinberg; Susan A Maloney; Luis S Ortega; Martin S Cetron
Journal:  PLoS One       Date:  2012-02-27       Impact factor: 3.240

6.  Cost-effectiveness of tuberculosis evaluation and treatment of newly-arrived immigrants.

Authors:  Travis C Porco; Bryan Lewis; Elliot Marseille; Jennifer Grinsdale; Jennifer M Flood; Sarah E Royce
Journal:  BMC Public Health       Date:  2006-06-19       Impact factor: 3.295

7.  Timing of therapy for latent tuberculosis infection among immigrants presenting to a U.S. public health clinic: a retrospective study.

Authors:  Kathleen R Page; Yukari C Manabe; Akintoye Adelakun; Lynn Federline; Wendy Cronin; James D Campbell; Susan E Dorman
Journal:  BMC Public Health       Date:  2008-05-12       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.